|
|
||||||||



*
Cooperative Research Centre for Vaccine Technology, Queensland Institute of Medical Research, P.O. Royal Brisbane Hospital, Brisbane; and
Walter and Eliza Hall Institute of Medical Research, P.O. Royal Melbourne Hospital, Melbourne, Australia
Apical membrane Ag 1 (AMA1) is a leading malaria vaccine candidate.
Homologues of AMA1 can induce protection in mice and monkeys, but the
mechanism of immunity is not understood. Mice immunized with a
refolded, recombinant, Plasmodium
chabaudi AMA1 fragment (AMA1B) can withstand subsequent
challenge with P. chabaudi adami. Here we show that
CD4+ T cell depletion, but not 
T cell depletion, can
cause a significant drop in antiparasite immunity in either immunized
normal or immunized B cell KO mice. In normal mice, this loss of
immunity is not accompanied by a decline in Ab levels. These
observations indicate a role for AMA1-specific Ab-independent T
cell-mediated immunity. However, the loss of immunity in normal
CD4+ T cell-depleted mice is temporary. Furthermore,
immunized B cell KO mice cannot survive infection, demonstrating the
absolute importance of B cells, and presumably Ab, in AMA1-induced
immunity. CD4+ T cells specific for a cryptic conserved
epitope on AMA1 can adoptively transfer protection to athymic
(nu/nu) mice, the level of which is enhanced by
cotransfer of rabbit anti-AMA1-specific antisera. Recipients of
rabbit antisera alone do not survive. Some protected recipients of T
cells plus antisera do not develop their own AMA 1-specific Ab
response, suggesting that AMA 1-specific CMI alone can protect mice.
These data are the first to demonstrate the specificity of any
protective CMI response in malaria and have important implications for
developing a malaria vaccine.
This article has been cited by other articles:
![]() |
J. M. Burns Jr., P. R. Flaherty, P. Nanavati, and W. P. Weidanz Protection against Plasmodium chabaudi Malaria Induced by Immunization with Apical Membrane Antigen 1 and Merozoite Surface Protein 1 in the Absence of Gamma Interferon or Interleukin-4 Infect. Immun., October 1, 2004; 72(10): 5605 - 5612. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rainczuk, T. Scorza, P. M. Smooker, and T. W. Spithill Induction of Specific T-Cell Responses, Opsonizing Antibodies, and Protection against Plasmodium chabaudi adami Infection in Mice Vaccinated with Genomic Expression Libraries Expressed in Targeted and Secretory DNA Vectors Infect. Immun., August 1, 2003; 71(8): 4506 - 4515. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Mueller, A. Renard, F. Boato, D. Vogel, M. Naegeli, R. Zurbriggen, J. A. Robinson, and G. Pluschke Induction of Parasite Growth-Inhibitory Antibodies by a Virosomal Formulation of a Peptidomimetic of Loop I from Domain III of Plasmodium falciparum Apical Membrane Antigen 1 Infect. Immun., August 1, 2003; 71(8): 4749 - 4758. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. O. Makobongo, G. Riding, H. Xu, C. Hirunpetcharat, D. Keough, J. de Jersey, P. Willadsen, and M. F. Good The purine salvage enzyme hypoxanthine guanine xanthine phosphoribosyl transferase is a major target antigen for cell-mediated immunity to malaria PNAS, March 4, 2003; 100(5): 2628 - 2633. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Kennedy, J. Wang, Y. Zhang, A. P. Miles, F. Chitsaz, A. Saul, C. A. Long, L. H. Miller, and A. W. Stowers In Vitro Studies with Recombinant Plasmodium falciparum Apical Membrane Antigen 1 (AMA1): Production and Activity of an AMA1 Vaccine and Generation of a Multiallelic Response Infect. Immun., December 1, 2002; 70(12): 6948 - 6960. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Stowers, M. C. Kennedy, B. P. Keegan, A. Saul, C. A. Long, and L. H. Miller Vaccination of Monkeys with Recombinant Plasmodium falciparum Apical Membrane Antigen 1 Confers Protection against Blood-Stage Malaria Infect. Immun., December 1, 2002; 70(12): 6961 - 6967. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Xu, J. Wipasa, H. Yan, M. Zeng, M. O. Makobongo, F. D. Finkelman, A. Kelso, and M. F. Good The Mechanism and Significance of Deletion of Parasite-specific CD4+ T Cells in Malaria Infection J. Exp. Med., April 1, 2002; 195(7): 881 - 892. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |